tiprankstipranks
Trending News
More News >

Capricor sinks after STAT report of cancelled FDA panel review

The shares are down 33%, or $3.93, to $8.01 in afternoon trading.

Don’t Miss TipRanks’ Half-Year Sale

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1